Torsten Dunkern

Senior Director, Head of "​In-vitro Biology and Biomarker Research Unit"​ at Grünenthal Group - Worthington, IA, US

Torsten Dunkern's Colleagues at Grünenthal Group
Martin Bertram

SVP Head of Group Controlling

Contact Martin Bertram

Johannes Krings

Director Marketing "Schmerz"

Contact Johannes Krings

Priscila Monteros

Global Product Owner Sales & Marketing

Contact Priscila Monteros

Thomas Geiss

Vice President, Head of Group Tax

Contact Thomas Geiss

Verena Arndt

Scientific Director - Head Human Disease Mechanisms

Contact Verena Arndt

Helge Engel

Head of Integration Management | Vice President

Contact Helge Engel

View All Torsten Dunkern's Colleagues
Torsten Dunkern's Contact Details
HQ
49-241-569-0
Location
Company
Grünenthal Group
Torsten Dunkern's Company Details

Grünenthal Group

Worthington, IA, US • 1000 - 4999 Employees
Major Drugs

The Grünenthal Group is an independent, family-owned, international research-based pharmaceutical company headquartered in Aachen, Germany. We are an entrepreneurial specialist delivering true benefits to patients. By sustainably investing in research and development above the industrial average, we are committing to innovation in order to treat unmet medical needs and bring value-adding products to markets. Grünenthal is a fully integrated research & development company with a long track record of bringing innovative pain treatments and state-of-the-art technologies to patients. Altogether, the Grünenthal Group is present in 32 countries with affiliates in Europe, Latin America and the US. Grünenthal products are sold in more than 155 countries and approx. 5,400 employees are working for the Grünenthal Group worldwide. In 2015, Grünenthal achieved revenues of € 1.2 bn. More information: www.grunenthal.com. Search fields for Licensing & Acquisition R&D (from late preclinical to late stage clinical development, focus on small indications, clear differentiation vs. standard of care) Perioperative care Inflammation (niches in rheumatic diseases and other inflammatory diseases) Niche indication and rare diseases Cancer Supportive Care Europe (marketed RX-products for the retail- and or / or hospital business) Pain Perioperative Care Inflammation Neurology/Psychiatry Cancer Supportive Care Bone disorders Movement disorders Latin America (marketed RX-products for the retail- and or / or hospital business) Urology Gynecology Pain Inflammation Neurology/Psychiatry Cancer Supportive Care Grünenthal's Innovative Medicines Unit: www.imu.grunenthal.com Grünenthal's innovative INTAC® technology: www.intac.grunenthal.com Jobs & Career: http://www.grunenthal.com/grt-web/Grunenthal_Group/Jobs-Career/Vacancies/134100187.jsp Imprint: http://grunenthal.com/grt-web/Grunenthal_Group/Service/Imprint/130200018.jsp

Europe: Pain (prescriptive drugs) Further indications Latin America: Pain Central Nervous System Gynecology Further indications R&D: Pain Inflammation
Details about Grünenthal Group
Frequently Asked Questions about Torsten Dunkern
Torsten Dunkern currently works for Grünenthal Group.
Torsten Dunkern's role at Grünenthal Group is Senior Director, Head of "​In-vitro Biology and Biomarker Research Unit"​.
Torsten Dunkern's email address is ***@grunenthal.com. To view Torsten Dunkern's full email address, please signup to ConnectPlex.
Torsten Dunkern works in the Pharmaceuticals industry.
Torsten Dunkern's colleagues at Grünenthal Group are Martin Bertram, Carsten Griebel, Johannes Krings, Priscila Monteros, Thomas Geiss, Verena Arndt, Helge Engel and others.
Torsten Dunkern's phone number is 49-241-569-0
See more information about Torsten Dunkern